S9925: Collecting and Storing Samples From Patients With Lung Cancer
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
RATIONALE: Collecting and storing samples of tissue, blood, and sputum from patients with cancer to study in the laboratory may help the study of cancer in the future.
PURPOSE: The purpose of this study is to collect and store tissue, blood, and sputum samples from patients with lung cancer to be tested in the laboratory.
| Condition | Intervention |
|---|---|
|
Lung Cancer |
Other: biologic sample preservation procedure |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Lung Cancer Specimen Repository Protocol, Ancillary |
- Establishment of a central lung cancer specimen repository to serve as a resource for current and future scientific studies [ Time Frame: From date of study activation to consolidation of specimen banks ] [ Designated as safety issue: No ]
- Correlation of clinicopathologic information in the Southwest Oncology Group clinical data base with results of studies using the repository [ Time Frame: From date of study activation to consolidation of specimen banks ] [ Designated as safety issue: No ]
- Test of new hypotheses with the specimens in the repository [ Time Frame: From date of study activation to consolidation of specimen banks ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples With DNA
Fixed tissue in paraffin blocks or slides, slides of buccal brushings, fresh frozen tissue peripheral blood, serum, plasma, white blood cells, and sputum.
| Enrollment: | 2264 |
| Study Start Date: | September 2000 |
| Estimated Study Completion Date: | June 2013 |
| Primary Completion Date: | November 2012 (Final data collection date for primary outcome measure) |
OBJECTIVES:
- Establish a central lung cancer specimen repository to serve as a resource for current and future scientific studies.
- Correlate clinicopathologic information in the Southwest Oncology Group clinical data base with results of studies using the repository.
- Test new hypotheses with the specimens in the repository.
OUTLINE: Peripheral blood, sputum, and biopsy specimens are collected from patients. Tissue samples are frozen and stored in a lung cancer specimen repository for later use in correlative studies.
PROJECTED ACCRUAL: Not specified
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Lung cancer patients registered to SWOG lung protocols.
DISEASE CHARACTERISTICS:
Enrolled on one of the following Southwest Oncology Group protocols:
- SWOG-8805, SWOG-9019, SWOG-9416, SWOG-9509, SWOG-S9900, SWOG-S0003, SWOG-S0023, SWOG-S0126, SWOG-S0435, SWOG-S0220, SWOG-S0222, SWOG-S0327, SWOG-S0310, SWOG-S0339, SWOG-S0342, SWOG-S0341, SWOG-S0509, SWOG-S0429, or SWOG-S0124
PATIENT CHARACTERISTICS: Not specified
PRIOR CONCURRENT THERAPY: Not specified
Contacts and Locations
Show 431 Study Locations| Study Chair: | Wilbur A. Franklin, MD | University of Colorado, Denver |
More Information
Additional Information:
No publications provided
| Responsible Party: | Southwest Oncology Group |
| ClinicalTrials.gov Identifier: | NCT00920010 History of Changes |
| Other Study ID Numbers: | CDR0000078624, S9925, U10CA032102 |
| Study First Received: | June 11, 2009 |
| Last Updated: | April 17, 2013 |
| Health Authority: | United States: Federal Government |
Keywords provided by Southwest Oncology Group:
|
non-small cell lung cancer small cell lung cancer |
Additional relevant MeSH terms:
|
Lung Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site |
Neoplasms Lung Diseases Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 16, 2013